OCT 09, 2020 5:07 PM PDT

Using CRISPR to Destroy Cancer Cells

WRITTEN BY: Carmen Leitch

A few days ago, researchers and Professors Jennifer Doudna and Emmanuelle Charpentier won the Nobel prize in Chemistry for their work developing the gene editor CRISPR/Cas9. Since it was created, the gene editor has been used in many ways in research labs and has even moved to human trials in the clinic.

Some diseases can be traced back to genetic errors, and in some cases, those errors have the potential to be repaired by the CRISPR/Cas9 system. In new research, scientists have now applied it to tumor cells in an effort to eliminate something called fusion genes; fusion oncogenes are only found in cancer cells. The work has been reported in Nature Communications.

Fusion genes come from the aberrant joining of fragments of DNA that arise from two different genes, an error that can occur during cell division. Cells that carry deleterious fusion genes will often simply die, but in some cases, the cell is unharmed by the fusion gene; the cell carrying the fusion gene may have a reproductive advantage that causes it to start multiplying and leads to the formation of a tumor in the case of fusion oncogenes.

"Many chromosomal rearrangements and the fusion genes they produce are at the origin of childhood sarcomas and leukemias," noted the lead co-author of the study, Sandra Rodríguez-Perales.

An untreated tumour on the left and on the right, a CRISPR-treated tumor. Cells are stained with a cell proliferation marker (Ki67); brown shows cells in the untreated tumour proliferating, but not in the CRISPR-treated tumour / Credit: CNIO

Fusion genes have been found in many tumor cells; they may be present in up to twenty percent of cancers including breast, brain, and lung tumors. Fusion oncogenes are an attractive therapeutic target because they’re not found in healthy cells.

CRISPR/Cas9 can target very specific places in the genome for edits. In this work, the researchers used it to remove fusion genes from cells and mouse models of both Ewing's sarcoma and chronic myeloid leukemia. The researchers tried to make the tumors destroy themselves.

 "Our strategy was to make two cuts in introns, non-coding regions of a gene, located at both ends of the fusion gene," explained study co-author Raúl Torres-Ruiz. "In that way, in trying to repair those breaks on its own, the cell will join the cut ends which will result in the complete elimination of the fusion gene located in the middle.” This particular gene is required for the cell to survive, so once the repair was made, the tumor cell died.

"Our next steps will be to carry out more studies to analyze the safety and efficiency of our approach," added Rodríguez-Perales. "These steps are essential to know if our approach can be translated in the future into a potential clinical treatment. Furthermore, we will study whether our strategy, which we have already seen works in Ewing's sarcoma and chronic myeloid leukemia, is also effective in other types of cancer caused by fusion genes and for which there are currently no effective therapies."

Sources: AAAS/Eurekalert! via Centro Nacional de Investigaciones Oncológicas (CNIO), Nature Communications

 

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 24, 2022
Neuroscience
Frankenworld: Should We Be Afraid of Playing God or Failing To Love Our Monsters?
OCT 24, 2022
Frankenworld: Should We Be Afraid of Playing God or Failing To Love Our Monsters?
Lawyer Henry T. Greely analyzes the relevance of Mary Shelley's classic, "Frankenstein," in light of today's bioscience
AUG 19, 2022
Microbiology
Rapid Genetic Mutation in a Relative of a Crop-Killing Bacterium
AUG 19, 2022
Rapid Genetic Mutation in a Relative of a Crop-Killing Bacterium
Citrus greening, known by several other names including yellow dragon disease, Huanglongbing, or Candidatus Liberibacter ...
SEP 16, 2022
Genetics & Genomics
Grad Student Highlights: Shannon Barry (Florida Institute of Technology)
SEP 16, 2022
Grad Student Highlights: Shannon Barry (Florida Institute of Technology)
This interview series is focused on the graduate student experience across all STEM fields that allows them to get their ...
SEP 26, 2022
Genetics & Genomics
Thousand-Year-Old Poop Teaches us About an Ancient Parasite
SEP 26, 2022
Thousand-Year-Old Poop Teaches us About an Ancient Parasite
Parasitic whipworm eggs have been isolated from fossilized human fecal samples that were estimated to be over 7,000 year ...
NOV 10, 2022
Neuroscience
HUSH - A Complex That Silences Genes & Helps Control Brain Architecture
NOV 10, 2022
HUSH - A Complex That Silences Genes & Helps Control Brain Architecture
The HUSH (human silencing hub) protein complex is known to silence genes, and researchers have thought that it could be ...
NOV 29, 2022
Cell & Molecular Biology
How a Master Regulator May be Working to Protect Cancer
NOV 29, 2022
How a Master Regulator May be Working to Protect Cancer
Scientists have now discovered yet another way that MYC proteins can promote cancer. MYC has been called a master regula ...
Loading Comments...